Retinal Vessel Diameter Changes in COVID-19 Infected Patients

Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and v...

Full description

Saved in:
Bibliographic Details
Published inOcular immunology and inflammation Vol. 29; no. 4; pp. 645 - 651
Main Authors Aşıkgarip, Nazife, Temel, Emine, Hızmalı, Lokman, Örnek, Kemal, Sezgin, Fikriye Milletli
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 19.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19). Methods: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission. Results: The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls (p = .007 and p = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline (p = .001, p = .019, p = .037, and p = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all p < .05). Conclusion: Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0927-3948
1744-5078
1744-5078
DOI:10.1080/09273948.2020.1853783